References
- Weinstein MC, Zeckhauser RJ. Critical ratios and efficient allocation. J. Public Econ. 2, 147–157 (1973).
- Devlin N. An introduction to the use of cost-effectiveness thresholds in decision-making: what are the issues? In: Cost-effectiveness thresholds; economics and ethical issues. Towse A, Pritchard C, Devlin N (Eds.). London, King Fund and Office of Health Economics. 16–23.
- Gafni A, Birch S. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. CMAJ 148, 913–917 (1993).
- O’Brien BJ, Gertsen K, Willan AR, Faulkner LA. Is there a kink in consumers’ threshold value for cost-effectiveness in healthcare? Health Econ. 11, 175–180 (2002).
- Kent DM, Fendrick AM, Langa KM. New and dis-improved: on the evaluation and use of less effective, less expensive medical interventions. Med. Decis. Making 24, 281–286 (2004).
- Dowie J. Why cost-effectiveness should trump (clinical) effectiveness: the ethical economics of the South West quadrant. Health Econ. 13, 453–459 (2004).
- Birch S, Gafni A. Changing the problem to fit the solution: Johannesson and Weinstein’s (mis) application of economics to real world problems. J. Health Econ. 12, 469–476 (1993).
- Birch S, Gafni A. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? J. Health Econ. 11, 279–296 (1992).
- Sendi P, Gafni A, Birch S. Opportunity costs and uncertainty in the economic evaluation of healthcare interventions. Health Econ. 11, 23–31 (2002).
- Al MJ, Feenstra TL, Hout BA. Optimal allocation of resources over healthcare programmes: dealing with decreasing marginal utility and uncertainty. Health Econ. (In Press).
- Sendi P. Some reflections on cost-effectiveness analysis and budget allocation in medicine. Exp. Rev. Pharmacoeconomics Outcomes Res. 2, 191–193 (2002).
- Gafni A, Birch S. NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales. Pharmacoeconomics 21, 149–157 (2003).
- Gafni A. Economic evaluation of healthcare interventions: an economist’s perspective. ACP J. Club 124, A12–A14 (1996).
- Sendi P, Al MJ, Gafni A, Birch S. Optimizing a portfolio of healthcare programs in the presence of uncertainty and constrained resources. Soc. Sci. Med. 57, 2207–2215 (2003).
- Gafni A, Birch S. Inclusion of drugs in provincial drug benefit programs: Should ‘reasonable decisions’ lead to uncontrolled growth in expenditures? CMAJ 168, 849–851 (2003).